| Integrative Genetic Variation, DNA Methylation, and Gene Expression Analysis of Escitalopram and Aripiprazole Treatment Outcomes in Depression: A CAN-BIND-1 Study F Islam, A Lisoway, ES Oh, LM Fiori, L Magarbeh, SSM Elsheikh, HK Kim, ... Pharmacopsychiatry, 2024 | | 2024 |
| Depression-anxiety coupling strength as a predictor of relapse in major depressive disorder: A CAN-BIND wellness monitoring study report A Nunes, B Pavlova, JEA Cunningham, JJ Nuñez, LC Quilty, JA Foster, ... Journal of Affective Disorders, 2024 | | 2024 |
| Self-harm presentations to hospital trauma centre emergency departments during the first year of the COVID-19 pandemic M Gordon, N Jayakumar, C Atzema, DJ Korczak, S Kennedy, A Schaffer, ... Psychiatry research 336, 115892, 2024 | | 2024 |
| Assessing remission in major depressive disorder using a functional-structural data fusion pipeline: A CAN-BIND-1 study S Ayyash, AD Davis, GL Alders, G MacQueen, SC Strother, S Hassel, ... IBRO Neuroscience Reports 16, 135-146, 2024 | 2 | 2024 |
| Large individual differences in functional connectivity in the context of major depression and antidepressant pharmacotherapy G van der Wijk, M Zamyadi, S Bray, S Hassel, SR Arnott, BN Frey, ... eneuro 11 (6), 2024 | 2 | 2024 |
| Predictors and correlates of outcome for dorsolateral, dorsomedial, and orbitofrontal rTMS in major depression PW Fettes, F Mazza, F Mansouri, L Schulze, F Vila-Rodriguez, ... | | 2024 |
| Progress in Biomarkers to Improve Treatment Outcomes in Major Depressive Disorder SR Vaccarino, AK Ceniti, S Rotzinger, SH Kennedy Clinical Textbook of Mood Disorders, 237, 2024 | | 2024 |
| 484. Exploring Pain Processing as a Potential Marker for Suicide Risk: An fMRI Study J Ma, T Salomons, W Gandhi, K Dunlop, N Churchill, T Schweizer, ... Biological Psychiatry 95 (10), S298, 2024 | | 2024 |
| 268. Subcallosal Cingulate Deep Brain Stimulation for Depression: Long-Term Safety and Effectiveness Outcomes From a Pooled Analysis of 172 Patients L Himes, H Mayberg, M Husain, P Holtzheimer, A Lozano, SH Kennedy, ... Biological Psychiatry 95 (10), S209-S210, 2024 | | 2024 |
| Canadian Network for Mood and Anxiety Treatments (CANMAT) 2023 Update on Clinical Guidelines for Management of Major Depressive Disorder in Adults: Réseau canadien pour les … RW Lam, SH Kennedy, C Adams, A Bahji, S Beaulieu, V Bhat, P Blier, ... The Canadian Journal of Psychiatry, 07067437241245384, 2024 | 3 | 2024 |
| Atypical brain aging and its association with working memory performance in major depressive disorder NCW Ho, RAI Bethlehem, J Seidlitz, N Nogovitsyn, P Metzak, PL Ballester, ... Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, 2024 | | 2024 |
| An empirical analysis of structural neuroimaging profiles in a staging model of depression N Nogovitsyn, P Ballester, M Lasby, K Dunlop, AK Ceniti, S Squires, ... Journal of Affective Disorders 351, 631-640, 2024 | | 2024 |
| Influence of CYP2C19, CYP2D6, and ABCB1 Gene Variants and Serum Levels of Escitalopram and Aripiprazole on Treatment-Emergent Sexual Dysfunction: A … F Islam, L Magarbeh, SSM Elsheikh, S Kloiber, CW Espinola, V Bhat, ... The Canadian Journal of Psychiatry 69 (3), 183-195, 2024 | | 2024 |
| Neuroanatomical dimensions in medication-free individuals with major depressive disorder and treatment response to SSRI antidepressant medications or placebo CHY Fu, M Antoniades, G Erus, JA Garcia, Y Fan, D Arnone, SR Arnott, ... Nature Mental Health 2 (2), 164-176, 2024 | 5 | 2024 |
| Factors Associated with Transition to Serious Mental Illness: Facteurs associés à la transition à une maladie mentale grave S Jalali, L Liu, JL Wang, SH Kennedy, G MacQueen, C Lebel, B Goldstein, ... The Canadian Journal of Psychiatry 69 (2), 79-88, 2024 | | 2024 |
| Ketamine-Assisted Psychotherapy Provides Lasting and Effective Results in the Treatment of Depression, Anxiety, and Post-Traumatic Stress Disorder at 3 and 6 Months: Findings … R Yermus, J Bottos, N Bryson, JA De Leo, M Earleywine, E Hackenburg, ... Psychedelic Medicine, 2024 | | 2024 |
| Prototyping the implementation of a suicide prevention protocol in primary care settings using PDSA cycles: a mixed method study N Minian, A Gayapersad, A Coroiu, R Dragonetti, L Zawertailo, J Zaheer, ... Frontiers in psychiatry 15, 1286078, 2024 | | 2024 |
| Stressful Life Events and Reward Processing in Adults: Moderation by Depression and Anhedonia S Min, R Mazurka, DA Pizzagalli, AE Whitton, RV Milev, RM Bagby, ... Depression and Anxiety 2024 (1), 8853631, 2024 | | 2024 |
| Functional neuroimaging biomarkers of anhedonia response to escitalopram plus adjunct aripiprazole treatment for major depressive disorder SR Vaccarino, S Wang, SJ Rizvi, W Lou, S Hassel, GM MacQueen, K Ho, ... BJPsych Open 10 (1), e18, 2024 | 1 | 2024 |
| Relation of hippocampal volume and SGK1 gene expression to treatment remission in major depression is moderated by childhood maltreatment: A CAN-BIND-1 report R Mazurka, S Cunningham, S Hassel, JA Foster, N Nogovitsyn, LM Fiori, ... European Neuropsychopharmacology 78, 71-80, 2024 | 1 | 2024 |
